The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123222407 12322240 7 F 20160421 20160915 20160502 20160923 EXP DE-SA-2016SA080913 AVENTIS 0.00 A F Y 97.00000 KG 20160923 OT DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123222407 12322240 1 PS LEMTRADA ALEMTUZUMAB 1 Intravenous drip EXACT DAILY DOSE NOT INDICATED, ONLY UNIT DOSE?DOSAGE TEXT: 1-0-0 UNKNOWN 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
123222407 12322240 2 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) DOSAGE; 1-0-0 UNKNOWN 0 1 G QD
123222407 12322240 3 C RANITIDINE ^RATIOPHARM^ 2 Intravenous (not otherwise specified) DOSAGE: 1-0-0 0 SOLUTION FOR INFUSION QD
123222407 12322240 4 C FAMPYRA DALFAMPRIDINE 1 0 BID
123222407 12322240 5 C VESIKUR SOLIFENACIN SUCCINATE 1 0 QD
123222407 12322240 6 C TAVEGIL CLEMASTINE FUMARATE 1 Intravenous (not otherwise specified) DOSAGE TEXT: 1-0-0 0 QD
123222407 12322240 7 C TAVANIC LEVOFLOXACIN 1 Oral DOSAGE TEXT; 1-0-0 0 500 MG TABLET QD
123222407 12322240 8 C MAYRA 2 Oral 0 QD
123222407 12322240 9 C ACICLOVIR ACYCLOVIR 1 0
123222407 12322240 10 C CETIRIZINE CETIRIZINE HYDROCHLORIDE 1 0
123222407 12322240 11 C PARACETAMOL ACETAMINOPHEN 1 0
123222407 12322240 12 C REKAWAN POTASSIUM CHLORIDE 1 0
123222407 12322240 13 C MONO-EMBOLEX CERTOPARIN SODIUM 1 Subcutaneous 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123222407 12322240 1 Multiple sclerosis
123222407 12322240 2 Prophylaxis
123222407 12322240 3 Prophylaxis
123222407 12322240 5 Urge incontinence
123222407 12322240 6 Prophylaxis
123222407 12322240 7 Urinary tract infection
123222407 12322240 8 Contraception

Outcome of event

Event ID CASEID OUTC COD
123222407 12322240 DE
123222407 12322240 HO
123222407 12322240 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123222407 12322240 Bradycardia
123222407 12322240 Cerebral haemorrhage
123222407 12322240 Hypertension
123222407 12322240 Nausea
123222407 12322240 Seizure
123222407 12322240 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123222407 12322240 1 20160418 20160420 0
123222407 12322240 2 20160418 20160420 0
123222407 12322240 3 20160418 20160420 0
123222407 12322240 6 20160418 20160420 0
123222407 12322240 7 20160418 20160420 0
123222407 12322240 9 20160418 0
123222407 12322240 10 20160418 0
123222407 12322240 11 20160418 0
123222407 12322240 12 20160418 0
123222407 12322240 13 20160418 0